Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
Christopher J.M. Williams(Hospital for Special Surgery), Sabine Tejpar(KU Leuven), Jenny F. Seligmann(University of Leeds), Pashtoon Murtaza Kasi(Cornell University), Allyson Peddle(KU Leuven), Campbell S.D. Roxburgh(Glasgow Royal Infirmary), Gary Middleton(University Hospitals Birmingham NHS Foundation Trust)
Cited by 69
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.2k
Colorectal cancer
|The Lancet|2019|5k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
|Cancer Immunology Research|2015|814